Infectious disease Archives

News and Trends 8 Jul 2016

Copenhagen-based Pcovery is looking to fight invasive Fungal Infections

After another visit to the United Kingdom, we ‘Brexit’ towards other geographies! We’re crossing the English Channel back to the continent and go further up to Denmark. This week, in Copenhagen, we’re visiting Pcovery, our Biotech of the Week. City: Copenhagen (Denmark) Founded: 2009 Employees: 6 Financial Data: €7.5M Total Raised (as of 12/2015) CEO: Casper Tind Hansen […]

July 8, 2016 - 2 minutesmins - By Joachim Eeckhout

zika sanofi niaid army us vaccine biotech

News and Trends 7 Jul 2016

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

Together with the US Walter Reed Army Institute of Research (WRAIR), the French infectious disease specialist, Sanofi Pasteur, hopes to speed up their promising new Zika virus vaccine. With the concerns over the borderline epidemic of the Zika virus, with its mysterious origins and not fully understood pathophysiology, the Biotech and pharmaceutical industries have united globally […]

July 7, 2016 - 4 minutesmins - By Dani Bancroft

abivax ceo ehrlich interview hiv hepatitis

News and Trends 4 Jul 2016

“We have one of the World’s Most Advanced Functional HIV Cures under development”

Abivax has recently announced that it’s likely that its most advanced program in hepatitis B will fail its Phase III trials. That’s really bad news for the company, and stocks have plummeted by around 50%. But what does this really mean for the future of Abivax? To find out, I had a chat with the company’s CEO Hartmut […]

July 4, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 27 Jun 2016

“France has always been a Leader in Infectious Disease and Microbiology”

This is what Franck Lescure, a partner at VC firm Auriga Partners, told me when I met him in Paris at his office next to the Champs-Elysées. Their last fund, Auriga IV Bioseeds, focuses on infectious disease and microbiology, with 6 investments so far and 9 by the end of 2016. It was a great way to […]

June 27, 2016 - 4 minutesmins - By Philip Hemme

venomab recombinant antivenom laustsen refresh

News and Trends 23 Jun 2016

‘Snake-bite Jesus’ pitched at Labiotech Refresh

VenomAb made quite an impression at the Startup Battle of Labiotech Refresh. Want to know what makes a biotech audience gasp unanimously? Then take a look at VenomAb’s pitch… We had Andreas Laustsen, founder of VenomAb, pitch his startup’s mission to bring antivenoms out of the 1900s into the modern age of biotech. The idea really captured […]

June 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

f2g fungal infections antifungals aspergillosis

News and Trends 22 Jun 2016

Massive Round: Novel Antifungals get €53M from Top-Notch Investors

F2G has raised €53M to advance its news class of treatments for life-threatening fungal infections, including invasive aspergillosis. The technology has attracted some of the major biotech investors in Europe. Based in Manchester (UK), F2G focuses on developing therapies for invasive fungal infections such as aspergillosis. This type of infections mostly affect patients that are […]

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

GMO Tobacco could Produce cheaper Medicine for Malaria

Researchers from the Max Planck Institute of Molecular Plant Physiology in Potsdam have altered tobacco to produce large yields of artemisinin – the most effective treatment for malaria but still without a cheap and reliable source. Artemisinin is used in the most effective treatments against malaria, the discovery of which was worth a Nobel Prize. […]

June 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

curetis blood infection diagnostic pathogen resistance

News and Trends 20 Jun 2016

This Sepsis Detection Test saves 24h for Faster Treatment

Curetis has received great results for its diagnostic kit. This new technology to detect sepsis is delivering the same results as standard tests, but it’s faster by 24 hours – critical time to deal with life-threatening infections. Based in Stuttgart (Germany), Curetis was the only German biotech to do an IPO in 2015. It did so with a bang, […]

June 20, 2016 - 2 minutesmins - By Denise Neves Gameiro

allecra forbion delos antibiotic resistance

News and Trends 16 Jun 2016

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Allecra Therapeutics has raised €22M in its Series B round from some key investors. The money will back the Phase II trials for a new broad-spectrum antibiotic for resistant bacteria. The development of antibiotic resistance in bacteria has been one of the key concerns of healthcare authorities for quite some time. The World Health Organisation estimates […]

June 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based immunotherapy has succeeded in targeting T-cells where HIV infection often ‘hides’ from drugs. Just after presenting promising results from its leading candidate at ASCO 2016 (read our coverage here), Immunocore is making headlines in another area – infectious disease. The […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

vaccination gates foundation vaccine delivery

News and Trends 10 Jun 2016

Gates Foundation is funding EU Biotech to make Vaccines more affordable

Batavia Biosciences has won a €3.3M grant from the Gates Foundation, to fund new research in making cell culture cheaper – and drive down the price of some key vaccines. Within its goal of pushing science forward and bringing to developing countries, the Gates Foundation has outlined vaccine delivery as a key part of its strategy. […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Jun 2016

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of potential place to visit. This week, we are heading down to the relaxing and sunny south of France, more precisely to Toulouse, once the capital of the Visigothic Kingdom and current to the Midi-Pyrénées region, the largest region in metropolitan France. It […]

June 10, 2016 - 2 minutesmins - By Joachim Eeckhout

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Infectious disease

Copenhagen-based Pcovery is looking to fight invasive Fungal Infections

Sanofi and the US Army team up for a Zika Vaccine, but why isn’t everyone else?

“We have one of the World’s Most Advanced Functional HIV Cures under development”

“France has always been a Leader in Infectious Disease and Microbiology”

‘Snake-bite Jesus’ pitched at Labiotech Refresh

Massive Round: Novel Antifungals get €53M from Top-Notch Investors

GMO Tobacco could Produce cheaper Medicine for Malaria

This Sepsis Detection Test saves 24h for Faster Treatment

Novel Antibiotic for Resistant Bacteria gets a €22M Push from Key Investors

Immunotherapy reaches Breakthrough in eliminating HIV

Gates Foundation is funding EU Biotech to make Vaccines more affordable

Genticel is vaccinating against Cervical Cancer AFTER Infection

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!